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Abstract 
Congenital cataract is a rare but severe paediatric visual impediment, often 
caused by variants in one of several crystallin genes that produce the bulk of 
structural proteins in lens. Here we describe a pedigree with autosomal 
dominant isolated congenital cataract and linkage to the crystallin gene cluster 
on chromosome 22. No rare single nucleotide variants or short indels were 
identified by whole-exome sequencing, yet copy number variant analysis 
revealed a duplication spanning both CRYBB1 and CRYBA4. While the 
CRYBA4 duplication was complete, the CRYBB1 duplication was not, with the 
duplicated CRYBB1 product predicted to create a gain of function allele. This 
association suggests a new genetic mechanism for the development of isolated 
congenital cataract. 
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Introduction  
Cataract is an opacification of the crystalline lens and one of the leading causes 
of blindness worldwide 1. Those that occur within the first year of life are 
categorized as congenital or infantile cataract, with an incidence in the order of 
52.8 per 100,000 children 2. Around 23% of non-syndromic congenital cataracts 
are familial 3, with around 50% of these associated with a crystallin gene variant 
4
. 
 
Crystallin proteins account for more than 90% of soluble lens protein, and can 
be divided into α-, β- and γ-crystallin families. With age, the closely related β- 
and γ-crystallins gradually form insoluble aggregates, which the chaperone-like 
α-crystallins serve to counteract. Ten human crystallin genes are known to be 
mutated in congenital cataract, with variants typically thought to reduce 
crystallin solubility directly (e.g. by creating an insoluble β- or γ-crystallin) or 
indirectly (e.g. due to loss of α-crystallin chaperone function) 5. These genes 
include both α-crystallins (CRYAA and CRYAB), two acidic β-crystallins 
(CRYBA1 and CRYBA4), three basic β-crystallins (CRYBB1, CRYBB2, and 
CRYBB3), and three γ-crystallins (CRYGC, CRYGD, and CRYGS) 4. 
 
The chromosomal arrangement of human crystallin genes reflects their 
evolutionary history, with major clusters on chromosomes 2 and 22 6. Of a total 
of eight γ-crystallin genes, six are located on chromosome 2. Similarly, all three 
basic β-crystallin genes (CRYBB1, CRYBB2, and CRYBB3) are located on 
chromosome 22, with the acidic β-crystallin CRYBA4 directly adjacent to 
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CRYBB1 (but transcribed in the opposite direction). This CRYBB1-CRYBA4 
arrangement is present in organisms as distant as zebrafish, and likely 
significant for their coordinate regulation. Either gene can lead to congenital 
cataract when mutated: CRYBA4 missense variants are known to cause 
dominant cataract 7, while CRYBB1 variants may be dominant 8 or recessive 9. 
 
Here we describe an autosomal dominant congenital cataract pedigree 
associated with a unique duplication of the paired CRYBB1-CRYBA4 locus. 
Both genes were found to be duplicated, with a complete duplication of 
CRYBA4 and partial duplication of CRYBB1. 
 
 
Materials & Methods 
Patients  
Clinical information from 19 members of pedigree CSA106 (Caucasian) was 
collected by referring ophthalmologists (see Table 1), with blood samples taken 
after informed written consent. Of these, 11 had developed bilateral cataracts. 
The study was approved by the Southern Adelaide Clinical Human Research 
Ethics Committee. 
 
Candidate gene panel screening 
Individual CSA106.03 (Figure 1A) was screened for variants in 51 known 
congenital cataract genes using an Ion AmpliSeq custom amplicon panel (Life 
Technologies). Genomic DNA concentration was measured with a dsDNA high 
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sensitivity Assay Kit on a Qubit fluorometer (Life Technologies). Library 
preparation (Ion AmpliSeq library kit v2.0) and template preparation (Ion PGM 
Template OT2 200 Kit) were performed according to the manufacturer’s 
instructions. The clonally amplified library was enriched on the Ion OneTouch 
enrichment system and quantified with a Bioanalyzer 2100 using the High 
Sensitivity DNA Kit (Agilent Technologies). Sequencing was performed on an 
Ion Torrent Personal Genome Machine (PGM) using The Ion PGM Sequencing 
200 Kit v2 and an Ion 318 chip (Life Technologies). Torrent Suite (v3.6) was 
used to align reads to the hg19 reference genome. The number of mapped 
reads, percentage of on-target reads, and mean read depth were calculated 
using the Coverage Analysis plugin (v4.0-r77897), and variants were called 
using the Variant Caller plugin (v4.0-r76860) with germline algorithm. Ion 
Reporter v4.0 was used for annotation. Variants were prioritized for further 
analysis if they were predicted to alter protein coding sense, were rare 
(MAF<0.001 in Exome Variant Server (EVS) 
(http://evs.gs.washington.edu/EVS/)), and were absent from unaffected 
controls. 
 
Exome sequencing 
A total of 11 members of the CSA106 family (6 affected, 5 unaffected) were 
subjected to exome sequencing, along with an additional 325 unrelated 
Australian cases and controls (a mixture of examined normal controls [20], 
cataract cases [22], keratoconus cases [51], advanced glaucoma cases [195], 
and primary congenital glaucoma cases [37]). Genomic DNA was extracted 
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from blood samples using a QIAamp Blood Maxi Kit (Qiagen) and subjected to 
exome capture (Agilent SureSelect v4). Paired-end libraries were then 
sequenced on an Illumina HiSeq 2000 by an external contractor (Axeq 
Technologies). Reads were mapped to the human reference genome (hg19) 
using the Burrows-Wheeler Aligner (v0.7.10), and duplicates were marked and 
removed using Picard (v1.126). An average of 49,429,126 reads per sample 
were mapped to capture regions, with a mean read depth of 83.6 and >10X 
coverage for 97.3% of the capture regions. Variants were called using SAMtools 
(v1.0) and annotated against RefSeq transcripts using ANNOVAR (2014Nov12) 
with additional annotations from the NHLBI Exome Sequencing Project 
(ESP6500SI-V2), 1000 Genomes Project (November 2014 release), ExAC 
(v0.3.1), and dbSNP138 databases. Variants were filtered by QUAL score 
(>20), and considered to be potentially pathogenic if predicted to alter protein 
coding sense (nonsynonymous, stopgain, stoploss, frameshift, essential splice), 
and were sufficiently rare (ExAC MAF<0.0001). CRYBB1 variants were 
annotated according to RefSeq accession numbers NG_009826.1, 
NM_001887.3 and NP_001878.1, with CRYBA4 variants based on 
NG_009825.1, NM_001886.2 and NP_001877.1.  
 
Linkage analysis 
VCF files were converted to MERLIN input format using the vcf2linkdatagen and 
linkdatagen scripts 10. Parametric linkage analysis was then performed using 
MERLIN (v1.1.2) under a fully penetrant dominant model with a disease 
frequency of 0.0001. 
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Exome CNV analysis 
Coverage depth across the critical region was extracted from exome BAM files 
using SAMtools (v1.3). For copy number variant analysis using CoNIFER 
(v0.2.2), the same interval was analysed in 343 population-matched control 
exomes (including 11 from family CSA106) using the following parameters: SVD 
5, ZRPKM 1.5. 
 
qPCR CNV analysis 
TaqMan Copy Number Assays for intron 3 (Hs04088405_cn: hg19 
chr22:g.27006444) and exon 6 (Hs00054226_cn: hg19 chr22:g.26995522) of 
CRYBB1 were ordered from ThermoFisher Scientific. All available CSA106 
family members were tested for partial duplication in CRYBB1 gene using 
genomic DNA according to manufacturer's protocol. Briefly, each region was 
amplified in four replicates on a StepOne Plus real-time PCR instrument 
alongside an endogenous reference gene (TaqMan Copy Number Reference 
Assay, human, RNase P). CopyCaller 2.0 software (Life Technologies) was 
used to predict the copy number of the target genomic DNA. Intron 3 was also 
screened in an additional 46 congenital cataract probands with an unidentified 
genetic cause (recruited under the same protocol as the CSA106 family). 
 
Whole-genome sequencing 
Genomic DNA from a single affected family member (CSA106.19) was 
extracted from a blood sample using a QIAamp Blood Maxi Kit (Qiagen). A 
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150bp paired-end library was generated using the TruSeq Nano kit (v2.5) and 
sequenced on an Illumina HiSeq X Ten system by an external contractor 
(Garvan Institute of Medical Research). 148.75Gb of sequence data was 
generated, with reads mapped to the human reference genome (hg19) using 
the Burrows-Wheeler Aligner (v0.7.12), and duplicates marked and removed 
using Picard (v2.6). 988,463,168 reads were mapped to the hg19 reference 
genome, with a mean read depth of 43.3 and >10X coverage for 96.8% of the 
genome. Local realignment and base quality recalibration was performed using 
the Genome Analysis Toolkit (GATK, v3.5). The predicted pathogenic variant 
identified in this study has been submitted to the ClinVar Database (accession 
number SCV000484507, https://www.ncbi.nlm.nih.gov/clinvar/). 
 
Lens protein extraction 
Cataractous lens material was collected from the proband during 
phacoemulsification (CSA106.6, aged 13 years), and stored in balanced salt 
solution with 2mM EDTA pH 8.0 at −80°C. Normal human lens was obtained 
from an 18 year-old deceased donor (Eye Bank of South Australia, Flinders 
Medical Centre), collection of which was approved by Southern Adelaide 
Clinical Human Research Ethics Committee. Lenses were homogenized in 2 
mL of extraction buffer containing 50 mM imidazole (pH 7), 50 mM NaCl, 2 mM 
6-aminohexanoic acid, 1 mM EDTA, and protease inhibitor cocktail (Roche 
Diagnostics), and ultracentrifuged at 150,000×g for 30 min at 4°C. The soluble 
fraction was acetone precipitated according to the Thermos Scientific protocol 
(Thermo Fisher). The insoluble fraction was dissolved in buffer containing 6 M 
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urea, 2% dichloro-diphenyl-trichloroethane (DTT), 2% 3-[C3-cholamidoproyl] 
dimethyl-ammonio-1-propansulfonat (CHAPS) and 0.1% sodium dodecyl sulfate 
(SDS). The EZQ Protein Quantitation method (Life Technologies) was used to 
determine protein concentration.  
 
Denaturing gel electrophoresis and Western blotting  
Twenty micrograms of total soluble protein from each lens was size fractionated 
by SDS-PAGE using a 12% polyacrylamide gel. The precision plus protein 
standards (BioRad) were used for size comparison. Fractionated proteins were 
transferred onto Hybond-C Extra nitrocellulose (GE Healthcare), and after 
blocking in 5% (wt/vol) milk in TBS-Tween (Tris Buffered Saline and 1% Tween-
20) was incubated with a mouse monoclonal anti-CRYBB1 primary antibody 
(1:400, Sigma-Aldrich, WH0001414M3). After washing the membrane was 
incubated with horseradish peroxidase (HRP) -conjugated goat anti-mouse IgG 
(1:1000, Jackson ImmunoResearch), and following another wash was treated 
with Clarity Western ECL Blotting Substrate (BioRad) or Amersham ECL Prime 
(GE Healthcare) and imaged using an ImageQuant LAS 4000 Imager (GE 
Healthcare). The same membrane was stripped at 50°C in stripping buffer 
(100mM β-mercaptoethanol, 2% SDS and 62.5 mM Tris-HCl [pH 7]) then 
reprobed with polyclonal rabbit anti-CRYBA4 (1:200, Abcam, ab130680) or 
polyclonal sheep anti-CRYΑA (1:1000; Flinders University Antibody Production 
Facility) primary antibodies, followed by HRP-conjugated goat anti-rabbit IgG or 
anti-sheep IgG secondary antibodies (1:1000, Jackson ImmunoResearch).  
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Results 
Autosomal dominant congenital cataract 
We identified a 6-generation autosomal dominant congenital cataract pedigree 
(Figure 1A), with multiple affected members diagnosed with nonsyndromic 
bilateral cataracts between birth and 10 years of age (Table 1). Slit lamp 
imaging of the lens demonstrated mild to dense fetal nuclear opacification with 
anterior and posterior sutural involvement (Figure 1B). A custom amplicon 
sequencing panel, designed to sequence 51 known congenital cataract genes 
(Supplementary Table 1), was first used to screen an affected family member 
(CSA106.03). A total of 807,055 reads were mapped to the reference genome, 
covering 93.21% of target gene bases to at least 20X depth (average read 
depth of 623.5 across 1216 amplicons). A total of 172 variants were identified: 
all 172 either had a mean allele frequency (MAF) of greater than 0.001, were 
present in control samples, or were not predicted to alter protein sequence. 
 
Linkage to chromosome 22 
Given the absence of a candidate variant in a known congenital cataract gene 
that affects function, we sequenced the exomes of 11 family members (6 
affected, 5 unaffected). Parametric linkage analysis under a rare dominant 
inheritance model revealed a peak LOD score of 3.3 on chromosome 22 (Figure 
2A,B). Haplotype phasing indicated that rs2236005 (hg19 
chr22:g.26422980A>G) and rs2347790 (hg19 chr22:g.29414001A>G) were the 
boundaries of the 3 Mbp critical region (Figure 2C), within which lay 17 protein-
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coding genes (plus 9 ncRNA and 7 pseudogenes) including the known 
congenital cataract genes CRYBB1 and CRYBA4 (Figure 2D). All 17 protein-
coding gene exons were covered by whole-exome capture sequencing, with 
CRYBB1 and CRYBA4 also having been previously covered by candidate gene 
amplicon sequencing. We detected two single-nucleotide variants that were 
shared between affected family members, absent from unaffected family 
members, and that altered coding sense (Figure 2E). Both variants had a MAF 
at least an order of magnitude greater than the estimated population incidence 
of congenital cataract (~0.000528), and therefore were considered extremely 
unlikely candidates. Synonymous variants in CRYBB1 or CRYBA4 – recently 
identified as a possible cause of crystallin misfolding 11 – were also not shared 
between affected members. 
 
Partial duplication of the CRYBB1-CRYBA4 locus 
We next investigated coverage depth across the linkage interval using two 
methods. Both CoNIFER (Figure 3A) and SAMtools (Figure 3B) revealed an 
increased coverage depth (and by inference increased copy number) at the 
CRYBB1-CRYBA4 locus of all affected individuals. Based on coverage of 
protein-coding exons across the locus, this CNV spanned between a minimum 
of 28.8 kbp (hg19 chr22:g.26997843_27026636) and a maximum of 1.15 Mbp 
(hg19 chr22:g.26995638_28146902), the smaller of which encompassed only 
two protein-coding genes (CRYBB1 and CRYBA4), and the larger of which also 
included a long non-coding RNA gene (MIAT) . This CNV (hg19 
chr22:g.(26995638_26997843)_(27026636_28146902)dup) was present in all 
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six affected family members, absent from all five unaffected family members, 
and was absent from a further 325 unrelated Australian exomes sequenced 
contemporaneously. Mean coverage depth analysis revealed that while all five 
captured exons of CRYBA4 appeared to be duplicated (representing the final 
five of six total exons), only the first five exons of CRYBB1 (of a total of six) 
appeared to have been duplicated (Figure 3B). Duplication of CRYBB1 intron 3 
was confirmed by qPCR in all affected family members, with a similar assay 
showing that distal exon 6 was not duplicated (Figure 3C,D). CRYBB1 and 
CRYBA4 variation was also manually inspected via Integrative Genomics 
Viewer, given that a variant in one CRYBB1-CRYBA4 locus of a total of three 
(two alleles plus the duplicated allele) may not be called as heterozygous by 
variant-calling algorithms. We also screened an additional 46 unsolved 
congenital cataract cases for CRYBB1 duplications, yet did not identify any 
further duplications (Figure 3E). 
 
To examine the effects of the CRYBB1-CRYBA4 duplication on protein 
expression, we prepared protein from the cataractous left lens of CSA106.06 
(removed during phacoemulsifcation) and from a non-cataractous control lens. 
An anti-CRYAA Western blot indicated equivalent loading between the cataract 
and control samples, and reprobing the same blot with anti-CRYBA4 and anti-
CRYBB1 blots revealed bands of the appropriate size (22kDa and 28kDa 
monomers, respectively) and similar density in both samples (Figure 3F). An 
additional band was detected with the anti-CRYBA4 antibody corresponding to 
a CRYBA4 dimer (44kDa), although no other bands were apparent. We did not 
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detect any additional anti-CRYBB1-reactive bands in the cataract sample in 
soluble fractions (Figure 3F), or insoluble fractions (data not shown), despite 
using an antibody raised against a peptide (NP_001878, p.37_138) that is not 
encoded by exon 6. 
 
Tandem duplication of the CRYBB1-CRYBA4 locus 
In order to define the nature of the duplication and the associated breakpoints, 
we performed whole-genome sequencing on genomic DNA from an affected 
family member (CSA106.19). Read depth analysis confirmed the presence of a 
78,928bp duplication at the CRYBB1-CRYBA4 locus (hg19 
chr22:g.26995597_27074524dup), the boundaries of which occurred 
immediately proximal to chr22:26995597, and distal to chr22:27074524 (Figure 
4A). This duplication encompassed the entirety of CRYBA4 and the long non-
coding RNA gene MIAT, but only partially involved CRYBB1. Importantly, the 
proximal duplication boundary occurred within exon 6 of CRYBB1, just 75bp 
distal to the site of the exon 6 qPCR probe used in Figure 3D. This also 
explains why a duplicated exon 6 was not detected by whole-exome 
sequencing, as there would be insufficient complementarity to the exon 6 
capture probe. 
 
The arrangement of multiple discordant mate pairs within the duplicated region 
(Figure 4A) suggested a direct tandem duplication 12. This was confirmed by 
BLAST alignments of split reads spanning the duplication breakpoint, which 
revealed a proximal breakpoint joining exon 6 of CRYBB1 to intergenic 
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sequence distal to MIAT (Figure 4B). No insertions, deletions, or other 
rearrangements were evident at either proximal or distal breakpoints, although 
there was 3bp of microhomology at the adjoining sequences of the proximal 
breakpoint (Figure 4B, underlined). A predicted consequence of this proximal 
breakpoint was the creation of a hybrid CRYBB1 gene. This gene encoded the 
expected CRYBB1 amino acid sequence up to and including amino acid 205 (a 
glutamine residue). Beyond this point (corresponding to the proximal 
breakpoint) the final 47 C-terminal amino acids, including the majority of the 
fourth and final 'Greek key' crystallin domain, are predicted to be replaced by 18 
unrelated amino acids encoded by intergenic sequence (Figure 4B, C). If 
transcribed, this product would also be predicted to avoid nonsense-mediated 
decay, as the premature termination signal occurs in the final exon. 
 
Discussion 
Here we describe an autosomal dominant congenital cataract pedigree with 
unambiguous linkage to chromosome 22. Despite the absence of a candidate 
single nucleotide variant in the coding regions of genes within the linked 
interval, we identified a partial direct tandem duplication of the CRYBB1-
CRYBA4-MIAT locus. Although we have not definitively ascribed pathogenicity 
to this duplication, there are precedents for both CRYBB1 and CRYBA4 
causing dominant congenital cataract.  
 
Variants in CRYBA4, for example, have been described in autosomal dominant 
congenital cataract 7,13. Both reports describe missense variants (c.225G>T 
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(p.(Gly64Trp)), c.242T>C (p.(Leu69Pro)), c.317T>C (p.(Phe94Ser))) which 
presumably promote cataract formation by creating a less soluble protein. Yet 
the CRYBA4 duplication described here covered the complete gene, did not 
contain any missense variants, and did not lead to any obvious change in 
protein expression. 
 
On the other hand, CRYBB1 variants appear to have two distinct pathways to 
cataractogenesis. The recessive CRYBB1 variants c.169delG 
(p.(Gly57Glyfs*107)) or c.2T>A (p.(Met1Lys)) are not expected to be expressed 
at all, and presumably cause cataracts by completely removing an important 
structural component 9,14. Conversely the dominant alleles such as c.658G>T 
(p.(Gly220*)) 8, c.737C>T (p.(Gln223*)) 15 and c.827T>C (p.(*253Arg)) 16 are 
predicted to cause cataract by disrupting the coding sequence of the final exon 
(exon 6), and creating a protein with reduced solubility. The hybrid CRYBB1 
gene created as a consequence of the duplication described here also disrupts 
the coding sequence of exon 6, and is associated with an autosomal dominant 
pattern of inheritance. We therefore consider it most likely that the CRYBB1 
duplication product is the disease-causing agent, despite the fact that we did 
not detect an appropriately-sized band by Western blotting. 
 
The absence of an additional CRYBB1 band on Western blot may still be 
consistent with a gain-of-function mechanism: for example, the duplicated 
CRYBB1 product may have only been transiently expressed, or has a shorter 
half-life than full-length CRYBB1. Conversely it may not have been synthesised 
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at all, and played no role in cataractogenesis in this family. Given this 
possibility, we have not excluded the possibility that CRYBA4 triplosensitivity 
was responsible for the cataractogenesis, which could conceivably alter the 
stoichiometry of crystallin subunits at a critical stage of lens development. It is 
also possible that local transcription is altered in the context of a tandem 
duplication, again raising implications for crystallin stoichiometry. Duplication of 
the MIAT long noncoding RNA seems the least likely explanation for 
cataractogenesis in this family, given the large body of evidence for CRYBB1 
and CRYBA4 in congenital cataract. 
 
More broadly, copy number variation is largely overlooked in many whole-
exome and whole-genome studies, perhaps due in part to the limited predicted 
contribution of CNVs to common disease 17. In cases where CNVs do play a 
role it is almost always deletions that are responsible, either in trans with a 
second deleterious allele, or by causing haploinsufficiency on their own. 
Increases in copy number are far less common in a disease setting, and when 
they do occur, they commonly involve complete genes. Ocular disease is no 
exception, with duplication or triplication of TBK1 in normal tension glaucoma 
being one example 18,19, and a complex NHS triplication in the congenital 
cataract-associated Nance–Horan syndrome being another 20. TBK1 CNVs 
associated with glaucoma cover the entire locus, so a mechanistic explanation 
has not been immediately obvious. In the case of the Nance–Horan syndrome 
triplication, disruption of NHS transcription is thought to explain the phenotype, 
which is consistent with the loss-of-function mechanism of other NHS variants 
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20
. In a third example, both deletions and duplications of the same gene 
(FOXC1) have been associated with anterior segment dysgenesis 21. 
 
Other diseases can be caused by partial gene duplication 22, including ~7% of 
cases of the X-linked Duchenne and Becker muscular dystrophies (DMD/BMD) 
23
. In the case of DMD these variants invariably cause a frameshift, whereas in 
BMD the reading frame is maintained 22. In both cases the predicted result is a 
loss or reduction in protein function. 
 
Duplication has been integral to the diversification of the crystallin gene family. 
In the family presented here, we show that crystallin duplication can also be 
associated with congenital cataract. This represents a previously undescribed 
genetic mechanism for the development of isolated congenital cataract, with 
implications for other inherited diseases that appear refractory to whole-exome 
or whole-genome sequencing. 
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Titles and legends to figures  
 
Figure 1. An autosomal dominant congenital cataract pedigree 
(A) CSA106 pedigree, indicating affected (black) and unaffected (white) 
members. Proband (CSA106.02) is indicated by an arrow. 
(B) Direct illumination (top panels) or retroillumination (bottom panels) of the 
same cataract from four family members, demonstrating mild to dense fetal 
nuclear opacification with sutural involvement. LE, left eye; RE, right eye. 
 
Figure 2. Linkage of the cataract phenotype to proximal chromosome 22q 
(A) Genome-wide LOD scores under a fully penetrant dominant inheritance 
model.  
(B) LOD scores across chromosome 22. 
(C) Haplotype analysis and critical recombinants across the interval. 
(D) List of protein-coding genes within the defined linkage interval, with 
previously known congenital cataract genes highlighted. Start and end 
coordinates refer to the hg19 reference sequence. 
(E) Filtering strategy to identify shared heterozygous coding variants within 
linkage interval. 
 
Figure 3. Partial duplication of the CRYBB1-CRYBA4 locus 
(A) CoNIFER output indicating a copy number gain within the captured portion 
of the linkage interval. 
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(B) Average read depth of affected (red) and unaffected (black) family members 
across the same interval shown in (A). Each peak represents a region covered 
by exome capture and sequencing, typically an exon. All five coding exons of 
both CRYBB1 and CRYBA4 were covered, with an additional region captured 
and sequenced for CRYBB1. The final peak at the CRYBB1 locus (i.e. furthest 
to left) represents the sixth and final exon. 
(C) Exon structure of CRYBB1 and location of qPCR probes used for copy 
number variant analysis. 
(D) qPCR validation of a duplicated (intron 3) and non-duplicated (exon 6) 
region of CRYBB1. Bars indicate copy number (CN) normalized to an internal 
control probe. 
(E) CRYBB1 duplication screening in unsolved congenital cataract cases. 
(F) Crystallin protein content in cataractous lens extracts. Control [C] and 
patient [P] lens extracts were subjected to Western blotting with the indicated 
antibodies. CRYAA served as a loading control, with the same blot probed 
sequentially with all three antibodies. 
 
Figure 4. A direct tandem duplication at the CRYBB1-CRYBA4 locus 
resulting in partial duplication of CRYBB1 
(A) Whole-genome sequencing depth across the CRYBB1-CRYBA4 locus of an 
affected family member (CSA106.19). Relative location of local transcripts, 
concordant (grey) and discordant (green) paired reads, and duplication 
boundaries are indicated below. 
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(B) Depiction of the CSA106 tandem duplication, showing the sequence of a 
150bp split read spanning the duplication breakpoint (gDNA) and its predicted 
translation product (protein). Red gDNA sequence aligns to exon 6 of the 
duplicated CRYBB1 gene, with black sequence aligning to a region distal to the 
long non-coding RNA, MIAT. A 3bp region of microhomology is underlined. 
Predicted translation of the mate pair sequence reveals 14 amino acids from the 
C-terminus of CRYBB1 (red), followed by an 18 amino acid read-through 
product and premature termination codon (black). 
(C) Domain structure of full-length CRYBB1 protein, and hybrid CRYBB1 
protein produced as a consequence of the CSA106 tandem duplication 
(CRYBB1dup). 
 
 
Table 1: Clinical details of CSA106 family members. All affected members had bilateral cataracts. 
y, years; LE, left eye; RE, right eye; VA, visual acuity; NA, not available.  
 
ID 
Age 
diagnosed 
(y)  
Exome 
sequenced 
Disease 
Status 
Age of 
surgery 
(y) (RE) 
Age of 
surgery 
(y) (LE)  
pre-
surgical 
VA (RE) 
pre-
surgical 
VA (LE) 
CSA106.01 5 Yes Affected 76 76 NA NA 
CSA106.02 0 Yes Affected 44 44 NA NA 
CSA106.03 0 Yes Affected 3 22 NA NA 
CSA106.04 3 Yes Affected 18 19 NA NA 
CSA106.05 - Yes Unaffected - - - - 
CSA106.06 4 No Affected 7 13 6/36 6/12 
CSA106.07 0 No Affected NA NA 6/15 6/15 
CSA106.08 - Yes Unaffected - - - - 
CSA106.09 - Yes Unaffected - - - - 
CSA106.10 - No Unaffected - - - - 
CSA106.11 - No Unaffected - - - - 
CSA106.12 NA No Affected NA NA NA NA 
CSA106.13 NA No Affected NA NA NA NA 
CSA106.14 10 Yes Affected 51  10 NA NA 
CSA106.15 - Yes Unaffected - - - - 
CSA106.16 NA No Affected 24  NA NA NA 
CSA106.17 - Yes Unaffected - - - - 
CSA106.18 - No Unaffected - - - - 
CSA106.19 NA Yes Affected NA NA NA NA 
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